NCPA, NACDS Applaud HHS for Including Pharmacies in the COVID-19 Vaccine Program
November 20th 2020The NCPA and NACDS both applauded the HHS announcement regarding the partnerships with national and regional chain pharmacies and independent pharmacies to maximize access to COVID-19 vaccines.
Read More
X-ray Study Explores Potential of Hepatitis C Drugs to Treat COVID-19
November 19th 2020The study was done in an effort to help quickly develop pharmaceutical treatments for COVID-19 by repurposing existing drugs known to effectively treat other viral diseases, according to the study authors.
Read More
Study: Bursts of Exercise Can Lead to Significant Improvements in Indicators of Metabolic Health
November 18th 2020The research team described how approximately 12 minutes of acute cardiopulmonary exercise affected more than 80% of circulating metabolites, including pathways linked to a wide range of favorable health outcomes, thus identifying potential mechanisms that could contribute to a better understanding of the cardiometabolic benefits of exercise.
Read More
FDA Review of BLA for Liso-Cel in Relapsed/Refractory Large B-Cell Lymphoma Delayed by COVID-19
November 18th 2020A review of the biologics license application for lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphoma following at least 2 previous therapies has been delayed.
Read More